New study tracks rare muscle disease to pave way for future treatments
NCT ID NCT05653544
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study follows 150 people with primary mitochondrial myopathy, a rare genetic muscle disease, to understand how the condition changes over time. Researchers will measure muscle function, biomarkers, and imaging to find signs of disease progression. The goal is to identify useful measures for future clinical trials, not to test a new treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could identify key markers of disease progression, helping design better clinical trials for future treatments.
- What could go wrong
- This is an observational study, not a treatment trial. It will not directly improve symptoms, and results may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRIMARY MITOCHONDRIAL MYOPATHIES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hospital Universitario 12 Octubre
RECRUITINGMadrid, Madrid, 28041, Spain